Marsh & McLennan Companies, Inc. (MRSH) Tops Q4 EPS by 14c

Marsh & McLennan Companies, Inc. (NYSE: MRSH) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $6.6 billion versus the consensus estimate of $6.56 billion.

For earnings history and earnings-related data on Marsh & McLennan Companies, Inc. (MRSH) click here.

You May Also Be Interested In

• FDA accepts Teva's drug application for Tourette syndrome therapy in children
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance